1-5 of 5
Mike Leach
Close
Sort by
Journal Articles

ACOPP Chemotherapy for Frontline Treatment of Older Patients with Hodgkin Lymphoma - a Pilot Study

Matthew Wilson, MD BSc, MRCP, Catherine Ogilvie, MD, Jennifer Travers, MD, Michelle Martin, Jonathan Allan, Pam McKay, MD, Mike Leach, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5285.
https://doi.org/10.1182/blood-2019-126704
Published: 2019
Journal Articles

Dapsone poisoning

Lyndsay McLeod-Kennedy, Mike Leach
Journal: Blood
Blood (2019) 133 (23): 2551.
https://doi.org/10.1182/blood.2019000201
Published: 2019
Journal Articles

Investigating the Efficacy of Ofatumumab and Rituximab in Abrogating the Survival of NOTCH1 Mutated Chronic Lymphocytic Leukaemic (CLL) Cells

Odette Middleton, Alison McCaig, Mike Leach, Alison Michie, Helen Wheadon
Journal: Blood
Blood (2014) 124 (21): 3289.
https://doi.org/10.1182/blood.V124.21.3289.3289
Published: 2014
Journal Articles

Dasatinib-Induced Apoptosis in Chronic Lymphocytic Leukaemia Is Abrogated by Selective Micro-Environmental Signals.

Alison M McCaig, MBChB, Mike Leach, FRCP, Alison M Michie, PhD
Journal: Blood
Blood (2009) 114 (22): 1264.
https://doi.org/10.1182/blood.V114.22.1264.1264
Published: 2009
Journal Articles

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

Clinical Trials & Observations
Geoff Hale, Peppy Rebello, Lee R. Brettman, Chris Fegan, Ben Kennedy, Eva Kimby, Mike Leach, Jeanette Lundin, Håkan Mellstedt, Paul Moreton, Andy C. Rawstron, Herman Waldmann, Anders Osterborg, Peter Hillmen
Journal: Blood
Blood (2004) 104 (4): 948–955.
https://doi.org/10.1182/blood-2004-02-0593
Published: 2004